Wnt proteins are critical for embryonic cardiogenesis and cardiomyogenesis by regulating different intracellular signalling pathways. Whereas canonical Wnt/β-catenin signalling is required for mesoderm induction and proliferation of cardiac progenitor cells, β-catenin independent, non-canonical Wnt signalling regulates cardiac specification and terminal differentiation. Although the diverse cardiac malformations associated with the loss of non-canonical Wnt11 in mice such as outflow tract (OFT) defects, reduced ventricular trabeculation, myofibrillar disorganization and reduced cardiac marker gene expression are well described, the underlying molecular mechanisms are still not completely understood. Here we aimed to further characterize Wnt11 mediated signal transduction during vertebrate cardiogenesis. Using Xenopus as a model system, we show by loss of function and corresponding rescue experiments that the non-canonical Wnt signalling mediator Rcsd1 is required downstream of Wnt11 for ventricular trabeculation, terminal differentiation of cardiomyocytes and cardiac morphogenesis. We here place Rcsd1 downstream of Wnt11 during cardiac development thereby providing a novel mechanism for how non-canonical Wnt signalling regulates vertebrate cardiogenesis.
Introduction
The heart is one of the first functional organs that develops during mammalian embryogenesis. During cardiogenesis, a population of common cardiac progenitor cells is specified within the migrating anterior mesoderm that later on splits into two different cardiac lineages called the first and second heart field (FHF, SHF), respectively. While the SHF mainly contributes to the outflow tract (OFT) as well as the right ventricle and provides a minority of cells to the atria, cells of the FHF form the left ventricle and the majority of both atria (Buckingham et al., 2005) . In Xenopus, cells of the SHF contribute to the OFT whereas cells of the FHF form the single ventricle and the two atria of the three chambered heart (Gessert and Kühl, 2009 ). Differentiation of cardiomyocytes of both lineages is regulated by cardiac specific transcription factors and extracellular growth factors that are interwoven into a complex gene regulatory network (Herrmann et al., 2012) .
Wnt proteins can activate different, interconnected intracellular signalling branches including canonical Wnt/β-catenin and the noncanonical Wnt/JNK and Wnt/Ca 2+ pathways (Gessert and Kühl, 2010) .
Through these pathways, Wnt signalling regulates diverse processes such as gene expression and cytoskeletal organisation resulting in differentiation, proliferation or cell migration. During cardiogenesis, Wnt/β-catenin signalling is required for mesoderm formation, supports proliferation of cardiac progenitor cells and inhibits terminal differentiation of cardiomyocytes. In contrast, non-canonical Wnt signalling mediated by JNK and activated by either Wnt11, Wnt5a or Wnt2 has been shown to support cardiac differentiation in several model systems including mice (Cohen et al., 2012) , quails (Eisenberg and Eisenberg, 1999; Eisenberg et al., 1997) , Xenopus laevis (Afouda et al., 2008; Pandur et al., 2002) , P19 embryonic carcinoma cells (Pandur et al., 2002) , murine embryonic stem cells (Chen et al., 2008; Onizuka et al., 2012; Rai et al., 2012; Terami et al., 2004; Ueno et al., 2007) , human embryonic stem cells (Mazzotta et al., 2016) and different adult stem cell types (Belema Bedada et al., 2005; Koyanagi et al., 2005) . Wnt11 knockout mice are characterized by OFT defects, thinner ventricular walls, reduced ventricular trabeculation, reduced expres-sion of cardiac specific transcription factors as well as disorganized sarcomeres (Cohen et al., 2012; Nagy et al., 2010; Zhou et al., 2007) . Whereas OFT defects in Wnt11 -/-mice were linked to JNK/ATF2/ CREBP mediated transcriptional regulation of TGFβ 2 (Zhou et al., 2007) , the molecular mechanisms underlying the ventricular phenotypes remained elusive. In Xenopus, two wnt11 genes are present with different functions during development. Wnt11b (formerly called Wnt11) is expressed early during cardiogenesis and is required for specification of cardiac progenitors (Afouda et al., 2008; Pandur et al., 2002) . In contrast, Wnt11a (formerly called Wnt11R) is involved later during development in regulating terminal differentiation and cardiac morphogenesis (Garriock et al., 2005; Gessert et al., 2008) . The effect of Wnt11a during cardiogenesis in Xenopus and zebrafish is at least partly mediated by the cell adhesion molecule Alcam (Choudhry and Trede, 2013; Gessert et al., 2008) . Consistently, loss of either Wnt11a or Alcam leads to disturbed cardiac differentiation and morphogenesis (Choudhry and Trede, 2013; Gessert et al., 2008) . Rcsd1 (CapZ interacting protein (CapZIP) in humans or duboraya in zebrafish) has been shown to be an intracellular mediator of noncanonical Wnt/JNK signalling and to interact with the actin capping protein, also named CapZ (Oishi et al., 2006) . CapZ binds to the barbed end of actin filaments and anchors this end of thin filaments of striated muscles at the Z-disc. In cardiomyocytes, CapZ is thereby required for proper sarcomere organisation (Frank et al., 2006) . Binding of RCSD1 to CapZ is considered to prevent CapZ from binding to the actin cytoskeleton (Hernandez-Valladares et al., 2010) thereby regulating actin dynamics (Eyers et al., 2005) . Binding of Rcsd1 to CapZ involves the capping protein interaction (CPI) motif of Rcsd1 (HernandezValladares et al., 2010) and is regulated by phosphorylation of Rcsd1 through JNK (Eyers et al., 2005) . In zebrafish, duboraya is expressed in cardiac tissue and its loss results in the formation of cardiac edema being indicative for cardiac malfunction (Oishi et al., 2006) . Despite the occurrence of cardiac edema, the cardiac phenotype of duboraya deficient fish was not further analysed. Hence, we hypothesized that Rcsd1 might be involved in the non-canonical Wnt11 loss of function phenotype in the heart.
Using Xenopus laevis as a model system, we demonstrate that Rcsd1 and its CPI domain are required for proper cardiac development downstream of Wnt11a. Loss of either Wnt11a or Rcsd1 leads to disturbed ventricular trabeculation, reduced marker gene expression and cardiac malformations. Thus, our data places Rcsd1 downstream of Wnt11a during vertebrate cardiogenesis.
Methods

Xenopus laevis embryos
Xenopus laevis embryos were obtained and cultured according to standard protocols and staged as described by Nieuwkoop and Faber (Nieuwkoop and Faber, 1975) . All procedures were performed according to the German animal use and care law and approved by the German state administration Baden-Württemberg (Regierungspräsidium Tübingen).
Protein alignment and phylogenetic tree
ClustalW2 from the EMBL-EBI homepage was used for amino acid sequence alignment, homology calculation and generation of the phylogenetic tree. Following published sequences were used: human RCSD1: NP_443094.3, mouse Rcsd1: NP_848708.2, rat Rcsd1: NP_ 001101819.1, chicken Rcsd1: NP_001025960.1, X. laevis Rcsd1: NP_ 001087940.1, X. tropicalis Rcsd1: XP_002936285.2, zebrafish Duboraya: NP_001038887.1.
Rcsd1 clones
Xenopus Rcsd1 was isolated from RNA, which was extracted from pooled embryos of different stages. The murine Rcsd1 clone was isolated from 13.5 dpc mouse embryonic heart cDNA. Deletion constructs were generated by inverse PCR using appropriate primers.
Morpholino oligonucleotide (MO) and RNA injections
All MOs were obtained by GeneTools, LLC, OR and resuspended in DEPC treated water. Wnt11a MO has been used as previously described with 30 ng per blastomere (Garriock and Krieg, 2007; Gessert et al., 2008) . For Rcsd1 depletion we designed three independent MOs with the following sequences: Rcsd1_MO: 5'-CCCCTCCATTTCCTTCCTGGCTTCA-3'; Rcsd1_MO2: 5'-CCTCTCGATTCTTCGGTGCAAGTTC-3'; Rcsd1_MO3: 5'-TGATATCCGCTGATTTCCCCTCCAT-3'. For control experiments, the standard Control MO by GeneTools was used. Rcsd1 MO or Control MO were injected either unilaterally or bilaterally into one or both dorso-vegetal blastomeres at eight-cell stage to target cardiac tissue. Bilateral injections were done for analysing the heart phenotype and unilateral injections for marker gene analyses. In the later case, the uninjected side served as an internal control. 0.5 ng gfp RNA was co-injected in all experiments as a lineage tracer and to ensure proper injection (Dorn et al., 2014) . MO concentrations for unilateral injections were: Rcsd1 MO: 10 ng; Rcsd1 MO2: 5-20 ng; Rcsd1 MO3: 5-10 ng. The functionality and efficiency of the MOs was tested by cloning of the corresponding MO binding sites in front of and in frame with GFP. For rescue experiments, 10 ng of Rcsd1 MO together with 1-2 ng RNA were injected per blastomere.
Whole mount in situ hybridization (WMISH), immunohistochemistry and histological sections
Whole mount in situ hybridization in Xenopus and mouse embryos was performed according to standard protocols (Hemmati-Brivanlou et al., 1990; Lufkin, 2007) . For whole mount fluorescent immunohistochemistry the primary antibody anti Cardiac Troponin T from DSHB (University of Iowa, USA) and secondary antibody Cy3-conjugated (Dianova, Hamburg, D) were used. Embryos from WMISH experiments were embedded in gelatine blocks and sectioned with a thickness of 25 µm using a vibrating microtome, while embryos stained for cardiac Troponin T were embedded in paraffin blocks and sectioned with a thickness of 10 µm using a Leitz 1512 rotation-microtome.
RNA isolation and RT-PCR assays
Total RNA of Xenopus embryos was isolated from stages 1 to 25. cDNA was generated using random primers and the SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). RT-PCRs were performed using the Phire Hot Start II DNA polymerase (Thermo Scientific, Waltham, MA, USA) and following primers: gapdh_RT_forward: 5'-GCCGTGTATGTGGTGGAATCT-3'; gapdh_RT_reverse: 5'-AAGTTGTC GTTGATGACCTTTGC-3'; rcsd1_RT_forward: 5'-GACCTCTCCGTTCAG CAGTC-3'; rcsd1_RT_reverse: 5'-GCAGCTCAGATTCCTCCTTG-3'.
Cardiac explants and quantitative RT-PCR (qPCR)
Cardiac explants were dissected from embryos at stage 28 or 33/34 after bilaterally injection of either 10 ng Control or Rcsd1 MO per blastomere and 0.5 ng gfp as lineage tracer. Total RNA was isolated using the peq-GOLD RNApure kit (Peqlab, Erlangen, D) . cDNA was generated using random primers and the SuperScript II reverse transcriptase (Life Technologies, Carlsbad, CA, USA). qPCR was performed using QuantiTec SYBR ® Green PCR Kit (Qiagen, Venlo) on 20 μl LightCylcer ® capillaries (Roche, Basel, Switzerland) . Following primers were used: gapdh_ qPCR_forward: 5'-GCCGTGTATGTGGTGGAATCT-3'; gapdh_qPCR_ reverse: 5'-AAGTTGTCGTTGATGACCTTTGC-3'; myh6_qPCR_forward: 5'-CAGATCATGGGTATGCAACAACAG-3'; myh6_qPCR_reverse: 5'-ATCTGCACTGAGGTGGCTCCT-3'; tnni3_qPCR_forward: 5'-CTGCCGA CGCC ATGATG-3'; tnni3_qPCR_reverse: 5'-GTTTGAGACTGGCCC GTAGGT-3'. Relative gene expression was normalized against the housekeeping gene gapdh.
Split YFP complementation assay
Split YFP (yellow fluorescent protein) complementation assays were performed in HEK293 cells as previously described (Tecza et al., 2011) .
The ORFs without stop codons of murine Rcsd1, Rcsd1ΔCPI, Rcsd1ΔNLS, CapZa and CapZb were cloned into the pSC-B vector (Agilent Technologies, Santa Clara, CA, USA) and further in frame into pVen1 or pVen2 vectors. For negative controls the unrelated Xenopus Pes1 and Ppan were used (Tecza et al., 2011) . Quantitative presentation of the data shown in A. C. The heart rate is significantly reduced in Wnt11a-depleted embryos. D-G. Analysis of cardiac Troponin T stained Wnt11a morphant hearts using OPT. Atrial width, ventricular width and a-v length were measured as indicated in E resulting in data provided in F. Measurement of the OFT was done as indicated in E. Data are given in G. Scale bar: 100 µm. H. Cardiac Troponin T (Tnnt2) staining shows that Wnt11a inhibition results in smaller and malformed hearts. Cross sections demonstrate a disturbed ventricular trabeculation (t). Scale bars: 100 µm. White arrowheads indicate disturbed trabeculation. a, atrium; bpm, beats per minute; n, number of independent experiments; N, number of analysed embryos; ng, nanogram; oft, outflow tract; v, ventricle. Error bars indicate standard error of the means (s.e.m.). *, p≤0.05; ****, p≤0.0001; calculated by a non-parametric Mann-Whitney rank sum test.
Cell culture and transfection
HEK293 and NIH3T3 cells were cultured in DMEM supplemented with penicillin (100 U/ml), streptomycin (100 mg/ml), 10% FCS at 37°C with 5% CO 2 . Cells were grown on fibronectin-coated glass cover slips. Cells were transfected with plasmids for 24 h using Lipofectamine2000 (Life Technologies, Carlsbad, CA, USA), fixed with 1x PBS, 4% PFA for 15 min and mounted in Dapi mounting medium (Dianova, Hamburg, D).
Imaging
Images of HEK293 and NIH3T3 cells were taken with a Zeiss Axiophot microscope. Xenopus embryos were imaged with a Leica M205FA or Olympus SZX12 microscope and sections with a Zeiss Axiophot or Olympus BX60. Images were processed using ImageJ and Adobe Photoshop CS6.
Optical projection tomography (OPT)
Optical projection tomography (OPT) was applied to obtain highresolution three dimensional (3D) images of the heart in Xenopus embryos. Stage 43 embryos were fixed with Dent's fixative (DMSO and methanol, 1:4) and stained with the anti-CT3 antibody (1:50) (DSHB, Iowa USA) and Cy3-conjugated antibody 1:100 (Dianova, D). Xenopus embryos were mounted in 1% low melting agarose (Lonza, USA) and dehydrated overnight in 100% methanol at RT in the dark. The samples were cleared overnight at RT with benzylalcohol and benzylbenzoate (1:2) and imaged with an OPT Scanner 3001 M (Bioptonics Microscopy, UK). Pictures were taken with 1024×1024 pixel and 0.9°r otation step. The reconstruction of the data was performed using the NRecon software (SkyScan 3001). Imaris software 5.0 (Bitplane, Zurich, CH) was used to analyse OPT data.
Statistics
Quantitative presentations of data depict error bars indicating standard error of the means. P-values were calculated by a nonparametric Mann-Whitney rank sum test using GraphPad Prism 6 software.
Results
Loss of Wnt11a in Xenopus mimics the loss of Wnt11 in mice
We aimed to better understand the molecular mechanisms underlying the cardiac Wnt11 loss of function phenotype using Xenopus laevis as a model. To this end we focussed on Wnt11a that is expressed in cardiomyocytes in Xenopus during stages of cardiac morphogenesis and terminal differentiation comparable to the murine Wnt11 homolog (Garriock et al., 2005; Gessert and Kühl, 2009; Sinha et al., 2015) . First, we asked whether loss of Wnt11a in Xenopus results in a phenotype similar to the Wnt11 knockout phenotype in mice and initiated a more detailed analysis of the Wnt11a morphant phenotype than previously published (Garriock et al., 2005; Gessert et al., 2008) . We injected a well-described and characterized Wnt11a antisense morpholino oligonucleotide (MO) (Garriock et al., 2005; Garriock and Krieg, 2007; Gessert et al., 2008) targeting cardiac tissue, which resulted in a knockdown of endogenous Wnt11a protein. Depletion of Wnt11a led to smaller hearts with disturbed morphology including a shortened and compressed OFT (Fig. 1A ,B and Suppl. Movie 1 and 2). Furthermore, Wnt11a morphant embryos revealed cardiac edema indicating an impaired cardiac function (Fig. 1A,B) and revealed a significant decrease in heart rate (Fig. 1C) .
Supplementary material related to this article can be found online at http://dx.doi.org/10.1016/j.ydbio.2017.02.014.
To investigate the Wnt11a morphant heart morphology in more detail we performed 3D imaging of affected embryos using optical projection tomography (OPT) and measured the heart size. We observed a significant decrease in atrial (a) as well as ventricular (v) width as well as in a-v length (Fig. 1D-F) . OPT measurements also indicated that the OFT was significantly smaller, in particular the length of the OFT was reduced (Fig. 1G ). Please note, that the quantitative measurements do not represent the in vivo size of cardiac structures due to possible fixation/dehydration artefacts. Moreover, the variance of data also reflects the size variability of a rhythmically contracting organ (see control MO injected hearts for an example). As control MO and Wnt11a MO injected embryos were fixed and treated in parallel these data nevertheless allow for a quantification of the above described phenotypes. Cardiac Troponin T staining on sections of morphant hearts illustrated a reduced ventricular trabeculation (Fig. 1H) . This was also apparent in serial sections derived from OPT images of Wnt11a MO (9 out of 14) (Suppl. Fig. 2 ) but not control MO (0 out of 14) (Suppl. Fig. 1 ) injected embryos. Garriock and colleagues (Garriock et al., 2005) described cardia bifida as one phenotype occurring in about 10% of the cases upon Wnt11a morpholino injections. Using OPT we could indeed observe duplicated heart structures in 2 out of 14 analysed embryos similar to a cardia bifida phenotype (Fig. 1D) . Additionally, Wnt11a-deficient embryos revealed impaired cardiac differentiation as shown previously (Gessert et al., 2008) (Fig. 5) . Taken together, this detailed description of the Wnt11a morphant phenotype indicates that loss of Wnt11a in Xenopus mimics several aspects of the cardiac phenotype of Wnt11 -/-mice (Cohen et al., 2012; Nagy et al., 2010; Zhou et al., 2007) . We conclude that Xenopus is a suitable model system to further study the effects of non-canonical Wnt signalling during terminal differentiation and morphogenesis of the heart.
Rcsd1 is expressed in cardiac tissue
Next, we aimed to describe the molecular mechanisms underlying the Wnt11a cardiac phenotype and searched for possible mediators of non-canonical Wnt signalling. Here we focussed on Rcsd1, since: I) Rcsd1 was shown to be expressed in cardiac progenitor cells in zebrafish, II) loss of Rcsd1 in zebrafish resulted in cardiac edema, and III) Rcsd1 had implicated to mediate non-canonical Wnt signalling (Oishi et al., 2006) . A phylogenetic tree using publicly available sequences revealed a close relationship of Rcsd1 between different species (Suppl. Fig. 3A) . Moreover, Rcsd1 is highly conserved across species.
For expression and functional analyses in Xenopus, we isolated Rcsd1 clones from different developmental stages. Interestingly, the predominant Rcsd1 variant expressed during Xenopus embryogenesis is C-terminally shorter than the published Xenopus Rcsd1 clone and the mouse homolog due to the use of an alternative splice site at the corresponding boundary between intron 6 and exon 7 (Suppl. Fig. 4) . RT-PCR analysis revealed that rcsd1 is weakly expressed maternally in Xenopus. Zygotic expression starts during specification of cardiac progenitor cells (stage 13) and continues till later stages ( Fig. 2A) . Whole mount in situ hybridization (WMISH) analysis indicated an expression of rcsd1 in the common cardiac progenitor population at stage 20 (Fig. 2C,K) . Expression in the cardiac mesoderm persists until later stages (Fig. 2E-N) . Cross sections revealed that rcsd1 is strongly expressed in the myocardium (Fig. 2M-N ) similar to the expression of wnt11a in Xenopus (Garriock et al., 2005; Gessert and Kühl, 2009 ). Like in Xenopus, Rcsd1 transcripts were detected in the cardiac crescent of mouse embryos at E7.7 (Fig. 2O) and at later stages in the developing murine heart (Fig. 2P,Q) . These observations in Xenopus and mouse are similar to the cardiac expression pattern noted for the zebrafish homolog duboraya (Oishi et al., 2006) .
Loss of Rcsd1 results in cardiac defects in Xenopus
To determine whether a loss of Rcsd1 interferes with heart development, we disrupted Rcsd1 function during cardiogenesis in Xenopus embryos. Therefore, we relied on antisense morpholino oligonucleotides (MOs) targeting the translation start site of endogenous rcsd1 mRNA. To exclude off-target effects, we used three different Rcsd1 MOs (one of which does not overlap with the other two) and tested their functionality prior to use (Suppl. Fig. 5 ). For this purpose, we cloned the corresponding MO binding sites in front of and in frame with GFP (constructs named Rcsd1 MO-GFP) and injected RNA coding for these constructs in the presence or absence of the different MOs into early Xenopus embryos (Suppl. Fig. 5B,C) . All three Rcsd1 MOs blocked the translation of GFP indicating the functionality of these constructs. In initial loss of function (LOF) experiments, all three MOs resulted in the same phenotype as described below in more detail. For reasons of simplicity, we here show data gained with Rcsd1 MO1, further on called Rcsd1 MO throughout the manuscript. For rescue experiments, we generated a full-length rcsd1 construct lacking the 5'UTR. As the Rcsd1 MO partially binds to the 5'UTR, the MO should not target this construct. To test this, we cloned the putative MO binding site of this construct in front of and in frame with GFP (Δ5' Rcsd1 MO-GFP). Co-injection of the MO together with RNA coding for this construct did not prevent GFP translation indicating that the above mentioned construct is not targeted by the Rcsd1 MO. This indicates that the full-length rcsd1 construct lacking the 5'UTR can be used for rescue experiments (Suppl. Fig. 5B) .
Loss of Rcsd1 function by injection of Rcsd1 MO interfered with normal cardiac development in a dose dependent manner (Fig. 3A,B) . At stage 43-45, isolated hearts of Rcsd1-depleted embryos were smaller in size and showed a disturbed morphology in comparison to Control MO injected embryos (Fig. 3A , Suppl. Movie 1 and 3). We also observed cardiac edema at stages 43-45 as recently described in duboraya morphant fish (Oishi et al., 2006; Fig. 3A) . Intriguingly, we noticed a reduced heart rate in Rcsd1 morphants (Fig. 3C) indicating that the loss of Rcsd1 results in a functional impairment of embryonic heart physiology.
As in case of the Wnt11a morphant hearts, we also quantitatively measured the size of affected Rcsd1 morphant hearts upon OPT and found a reduced atrial width, ventricular width as well as a-v length (Fig. 3D-F) . Some Rcsd1 morphant hearts initiated the looping process but failed to complete this process (9 out of 17) (Fig. 3A, right heart) or showed a duplicated or triplicated ventricle (6 out of 17) similar to a cardia bifida phenotype. Rcsd1 morphant hearts also revealed a shortened and compressed OFT (Fig. 3A, middle heart, Fig. 3G ). Moreover, ventricular trabeculation was reduced and the trabeculae were located irregularly in Rcsd1-deficient embryos (Fig. 3H , white arrowhead). This was also evident in serial sections derived from OPT image stacks (Suppl. Fig. 6 ) (10 out of 17 embryos). Heart rate and heart morphology could be rescued by co-injecting Xenopus full-length rcsd1 (Fig. 3B,C) . Also trabeculation was improved upon reintroducing full-length rcsd1 (Fig. 3H) . These rescue experiments demonstrate the specificity of the Rcsd1 MO-induced cardiac phenotype. Overall these data show that Rcsd1-depleted embryos exhibit a cardiac phenotype remarkably similar to Wnt11a-deficient embryos.
Loss of Rcsd1 interferes with cardiac differentiation
Next, we were interested whether loss of Rcsd1 affects cardiac specification or differentiation and thus analysed the expression of a variety of cardiac marker genes in Xenopus. For this purpose, we injected the Rcsd1 MO unilaterally into embryos at 8-cell stage to target the cardiac primordium only on one side of the embryo. In this experimental setting, the un-injected side served as an internal control. As rcsd1 is expressed in the common cardiac progenitor cell population, we first analysed the expression of nkx2-5, isl1 and tbx20 characterizing this cell population at stage 20 (Gessert and Kühl, 2009 ) but did not observe any significant change in marker gene expression (Fig. 4A,B) . This indicates that Rcsd1 is not required for specification of cardiac progenitor cells.
Next, we investigated the expression of marker genes at stage 28 when cardiac differentiation takes place (Gessert and Kühl, 2009 ). Loss of Rcsd1 resulted in a down-regulation of tbx20, tnni3, actc1, myh6 and alcam as shown by WMISH (Fig. 4C,D) . Tnni3, actc1, myh6 and alcam expression could be significantly rescued by co-injection of Gapdh was used as loading control. Negative controls (-RT) were performed without reverse transcriptase (RT). Rcsd1 is weakly expressed maternally. Zygotic rcsd1 expression starts at stage 13. B-N. Spatial expression of rcsd1 at different developmental stages as indicated in Xenopus. Rcsd1 expression is first detected in the common cardiac progenitor at stage 20 (black arrowhead). Cardiac expression persists until later stages (black arrowheads). In addition, rcsd1 transcripts were detected in the somites (white arrowheads) and myeloid cells (red arrowheads). K-N. Cross section through the cardiogenic region of Xenopus embryos as indicated by the black dashed lines in C, E, G and I, respectively. Expression in cardiac tissue is detected at stage 20 (K, sagittal section), 24 (L, transversal section), 30 (M, transversal section) and 38 (N, transversal section). e, endocardium; m, myocardium; me, mesocardium; p, pericardium; r, pericardial roof. O-Q Expression of Rcsd1 during mouse embryogenesis. Rcsd1 is expressed in the developing murine heart at embryonic stages E7.7 (O), E8.25 (P) and E9.0 (Q).
A. Hempel et al. Developmental Biology 424 (2017) [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] Xenopus full-length rcsd1 RNA (Fig. 4G,H) . Reduced expression of tnni3 and myh6 could be confirmed by qPCR at stages 28 and 33/34 (Fig. 4E,F) . Please note that expression of alcam, a known target gene of Wnt11a (Choudhry and Trede, 2013; Gessert et al., 2008) , was also down-regulated in Rcsd1-deficient embryos indicating that both, Wnt11a and Rcsd1, are upstream of Alcam during vertebrate heart development ( Fig. 4C,D) .
Rcsd1 is required downstream of Wnt11a
To probe whether Wnt11a and Rcsd1 are functionally linked during cardiogenesis, we attempted to rescue the Wnt11a phenotype by rcsd1 RNA co-injection. Wnt11a MO injection resulted in a down-regulation of tnni3, actc1 and myh6 as shown earlier (Gessert et al., 2008 ; Fig. 5  A,B) . Of note, also rcsd1 is down-regulated upon loss of Wnt11a (Fig. 5   Fig. 3 . : Loss of Rcsd1 phenocopies the loss of Wnt11a. A. Depletion of Rcsd1 results in a severe cardiac phenotype characterized by cardiac edema (lateral view, red arrowheads) and heart malformations (ventral view, dotted lines; isolated hearts) at indicated stages. Scale bars: lateral view: 1000 µm; ventral view: 250 µm; isolated hearts 100 µm. B. Quantitative presentation of the data shown in A at stage 43. Rcsd1 MO injection leads to a cardiac phenotype in a dose dependent manner (red columns) compared to control MO injected embryos (blue column). Co-injection of full-length Xenopus rcsd1 RNA rescues the cardiac phenotype upon Rcsd1 deficiency (black column). C. Bilateral injection of Rcsd1 MO leads to a reduced heart rate (beats per minute, bpm) at stage 43, which is rescued by co-injecting full-length Xenopus rcsd1 mRNA. D-G. Analysis of cardiac Troponin T stained Rcsd1 morphant hearts using OPT. Atrial width, ventricular width and a-v length were measured as indicated in E resulting in data provided in F. Measurement of the OFT was done as indicated in E. Data are given in G. Scale bar: 100 µm. H. Cardiac Troponin T (Tnnt2) staining and sectioning of Control and Rcsd1 depleted embryos at stage 43. Loss of Rcsd1 leads to malformed hearts with disturbed ventricular trabeculation (t, white arrowheads). Rcsd1 injection restores the Rcsd1 MO induced phenotype. Scale bars: 100 µm. a, atrium; n, number of independent experiments; N, number of analysed embryos; ng, nanogram; oft, outflow tract; v, ventricle. Error bars indicate standard error of the means (s.e.m.). *, p≤0.05; **, p≤0.01; ***, p≤0.001; ****, p≤0.0001; calculated by a non-parametric Mann-Whitney rank sum test.
A. Hempel et al. Developmental Biology 424 (2017) 28-39 C,D). Co-injection of Wnt11a MO together with Xenopus full-length rcsd1 mRNA reversed the loss of marker genes observed in Wnt11a morphants suggesting that Rcsd1 acts downstream of Wnt11a during cardiogenesis (Fig. 5 A,B) . Interestingly, alcam down-regulation by loss of Wnt11a (Gessert et al., 2008) is also rescued by rcsd1. As alcam is downstream of Wnt11a (Gessert et al., 2008) and alcam is a direct transcriptional target of non-canonical Wnt signalling (Cizelsky et al., 2014) , our data strongly suggest that Rcsd1 acts as a mediator of Wnt11a signalling in this context.
Rcsd1 interacts with CapZ in the cytoplasm via its CPI motif
To elucidate the function of Rcsd1 during vertebrate cardiogenesis in more detail, we performed cellular localization studies by overexpressing a murine EGFP-RCSD1 fusion protein in NIH3T3 cells. Expression of this fusion protein was observed in the cytosol as well as in the nucleus (Fig. 6C, upper row) . One characteristic motif of Rcsd1 is the highly conserved CPI motif (Hernandez-Valladares et al., 2010; Suppl. Fig. 3B-D, Fig. 6A,B) . Deletion of this motif (Rcsd1ΔCPI) resulted in exclusive localization of the protein in the cytosol (Fig. 6C, middle row) . In-silico analysis of the Rcsd1 sequence revealed the presence of a putative nuclear localization signal (NLS) in the C-terminal part of the CPI motif (Suppl. Fig. 3B-D, Fig. 6A,B) . Deletion of this short sequence in EGFPRcsd1 (Rcsd1ΔNLS) was sufficient to exclude Rcsd1 from the nucleus (Fig. 6C, lower row) indicating that the NLS is functional.
In order to examine whether full-length Rcsd1 and the described deletion mutants Rcsd1ΔCPI and Rcsd1ΔNLS can interact with CapZ in vivo, we performed a bimolecular fluorescence complementation assay (split YFP assay) (Kerppola, 2008a (Kerppola, , 2008b Tecza et al., 2011) using murine Rcsd1 and CapZ YFP fragment fusion constructs. CapZ is a heterodimer consisting of CapZa and CapZb subunits (Cooper and Sept, 2008) . The open reading frame of Rcsd1 was fused in frame with the Nterminal part of YFP, whereas CapZa or CapZb were cloned in frame with the C-terminal part of YFP. Co-transfection of Rcsd1 and CapZa or CapZb into HEK293 cells resulted in a strong cytosolic YFP signal confirming the direct interaction between Rcsd1 with CapZa and CapZb as described earlier (Eyers et al., 2005; Hernandez-Valladares et al., 2010 ; Fig. 6D, E, upper rows) . Deleting the CPI motif led to a loss of interaction between Rcsd1 and CapZ, whereas the deletion of the NLS had no influence on the Rcsd1-CapZ interaction (Fig. 6D , E, middle and lower rows). All fusion proteins did not interact with functionally unrelated proteins (Suppl. Fig. 7 ). These data show that distinct domains of Rcsd1 are required for its cellular localization and interaction with CapZ.
The CPI motif of Rcsd1 is required for Rcsd1 function during cardiogenesis
Having these data at hand provided us with the opportunity to analyse the mode of action of Rcsd1 in more detail. The injection of Rcsd1 MO led to a down-regulation of marker genes for cardiac differentiation at stage 28. This phenotype could be restored by co-injecting full-length murine Rcsd1 (Fig. 6F,G ) similar to full-length Xenopus rcsd1 (Fig. 4G,H) . In contrast, murine Rcsd1ΔCPI did not rescue the Rcsd1 LOF phenotype (Fig. 6F,G) suggesting that either the interaction of Rcsd1 with CapZ (Fig. 6D,E) is required for proper Rcsd1 function or that Rcsd1 functions in the nucleus during cardiogenesis since Rcsd1ΔCPI is also excluded from the nucleus (Fig. 6C) . To distinguish between these two alternative hypotheses, we made use of the Rcsd1ΔNLS construct that is excluded from the nucleus but still interacts with CapZ ( Fig. 6C-E) . Co-injection of Rcsd1 MO together with Rcsd1ΔNLS significantly rescued the loss of Rcsd1 phenotype (Fig. 6F,G) .
Finally, we investigated whether both deletion constructs were able to rescue the late cardiac phenotypes upon loss of Rcsd1 function. Rcsd1ΔNLS but not Rcsd1ΔCPI was able to rescue overall cardiac morphology (Fig. 7A,B) comparable to murine full-length Rcsd1. Similarly, Rcsd1ΔNLS but not Rcsd1ΔCPI partially rescued ventricular trabeculation (Fig. 7A ) and heart beating rate (Fig. 7C) .
In summary, these data suggest that Rcsd1 function during cardiac development depends on the interaction with CapZ but is independent of its nuclear localization.
Discussion
Non-canonical Wnt signalling has been earlier linked to cardiogenesis in multiple organisms during different phases such as specification A. Hempel et al. Developmental Biology 424 (2017) 28-39 (Cohen et al., 2012; Onizuka et al., 2012; Pandur et al., 2002; Rai et al., 2012) , terminal differentiation (Gessert et al., 2008; Nagy et al., 2010) and cardiac morphogenesis (Choudhry and Trede, 2013; Garriock and Krieg, 2007; Gessert et al., 2008; Zhou et al., 2007) . Wnt11 knockout mice are characterized by smaller hearts and shortened OFTs (Cohen et al., 2012; Zhou et al., 2007) , deficits in ventricular trabeculation and cardiac differentiation as well as spatially disorganized sarcomeres (Nagy et al., 2010) . The molecular mechanisms involved in mediating this non-canonical Wnt signal were only rudimentary understood so far. Our study introduces Rcsd1 as a critical downstream mediator of non-canonical Wnt signalling required for these processes.
Wnt11 activates several signalling branches during cardiogenesis: potential involvement of Rcsd1
Earlier studies suggested two different signalling activities for Wnt11 function in cardiogenesis. During cardiac specification, Wnt11 (and Wnt5A) signalling can inhibit canonical Wnt/β-catenin signalling interact with CapZa and CapZb whereas Rcsd1ΔCPI (labelled as ΔCPI) does not. Scale bars D, E: 10 µm. F. Rcsd1 MO was unilaterally injected along with different murine Rcsd1 constructs and the expression of the cardiac markers tnni3, actc1, myh6 and alcam was monitored at stage 28 (ventral views). Reduced marker gene expression upon loss of Rcsd1 (red arrowheads) was rescued by co-injection with the full-length murine Rcsd1 construct (Rcsd1, dark grey arrowheads) and Rcsd1ΔNLS (dark blue arrowheads). Rcsd1ΔCPI however (orange arrowheads) was not able to restore marker gene expression. G. Quantitative presentation of data shown in F. n, number of independent experiments; N, number of analysed embryos. Error bars indicate standard error of the means (s.e.m.). n.s., not significant, *, p≤0.05; **, p≤0.01; ***, p≤0.001; calculated by a non-parametric Mann-Whitney rank sum test.
A. Hempel et al. Developmental Biology 424 (2017) ( Abdul-Ghani et al., 2011; Cohen et al., 2012; Pandur et al., 2002) , e.g. both factors down-regulate the Wnt/β-catenin reporter TOPFLASH during early stages of cardiac differentiation of murine ES cells (Cohen et al., 2012 ). The precise inhibitory mechanism of Wnt11 during specification however is not yet fully understood but activation of JNK signalling (Chen et al., 2014; Onizuka et al., 2012; Pandur et al., 2002; Rai et al., 2012) or proteases of the caspase family (Abdul-Ghani et al., 2011; Bisson et al., 2014) were discussed so far. Caspases have been shown to be able to cleave β-catenin and thus might be involved in the Wnt11 mediated inhibition of Wnt/β-catenin signalling (AbdulGhani et al., 2011) . Our data presented here indicate that very likely, Rcsd1 is not part of this signalling cascade. First, loss of Rcsd1 in Xenopus does not affect cardiac specification (see Fig. 4 ). It is noteworthy to mention, however, that this early contribution might be obscured by the maternally expressed Rcsd1, which is not targeted by the MO approach. Second, we were not able to detect any influence of Rcsd1 on the Wnt/β-catenin signalling pathway by the use of the TOPFLASH reporter (data not shown). Later during cardiogenesis, Wnt11 mediated JNK signalling and regulation of target genes through ATF2 transcription factors are of relevance. TGFβ 2 has been shown to be a target gene of this signalling branch during OFT formation in mice (Zhou et al., 2007) . In Xenopus, zebrafish and likely human ES cells, the cell adhesion molecule Alcam is regulated through this pathway (Choudhry and Trede, 2013; Gessert et al., 2008; Mazzotta et al., 2016) . Our lab showed that alcam is a direct target of non-canonical Wnt/JNK/ATF2 signalling (Cizelsky et al., 2014) . As Rcsd1 is also a regulator of alcam expression and as Rcsd1 can rescue the expression of alcam upon loss of Wnt11a function it is likely that Rcsd1 functions as a mediator of Wnt11a function in this context.
We also observed a down-regulation of rcsd1 on a transcriptional level upon loss of Wnt11a. Whether Rcsd1 thus is not only a mediator but also a transcriptional target of non-canonical Wnt signalling awaits further analysis. Indeed, several mediators of canonical, β-catenin mediated Wnt signalling such as Axin2, Dkk1 or Fzd7 are also direct targets of this pathway (see the Wnt homepage at http://web.stanford. edu/group/nusselab/cgi-bin/wnt/target_genes for a list of target genes and references). To our knowledge this has not yet been described for β-catenin independent signalling. It may also well be that the downregulation of rcsd1 in Wnt11a morphants reflects a more indirect effect as rcsd1 has been shown to be regulated by cardiac transcription factors such as members of the GATA family (Novikov and Evans, 2013) .
Insights into the molecular mechanisms of Rcsd1 function
Rcsd1 belongs to a protein family capable to interact with the capping protein (CapZ) that in turn binds to the barbed end of actin filaments thereby preventing further addition of G-actin. This interaction requires the CPI motif of Rcsd1. Our LOF studies and rescue experiments implicate Rcsd1 downstream of Wnt11a, the Xenopus homolog of Wnt11, during cardiogenesis. Furthermore, Rcsd1 activity requires the interaction with CapZ thereby presumably regulating the actin cytoskeleton during cardiogenesis. Proteins interacting with the capping protein have different functions, e.g. the recruitment of the active capping protein to the actin filament, the modulation of the actin cytoskeleton branching density or the inhibition of the capping protein activity thereby uncapping actin filaments (Edwards et al., 2014) . Indeed, knockdown of the Rcsd1 homolog duburaya in zebrafish resulted in a strongly reduced F-actin network in Kupffer's vesicle (Oishi et al., 2006) . As interaction of the capping protein with actin is required for modulating the apical actin network and since the actin network is required for cell movements, it is tempting to speculate whether the here observed cardiac morphological changes in Wnt11a or Rcsd1 deficient Xenopus hearts such as looping defects are due to changes in the actin network.
Phosphorylation of Rcsd1 by JNK reduces its affinity to CapZ. Six conserved serine residues in Rcsd1 were identified to be phosphorylated by different MAPK family members (Eyers et al., 2005) . Two of these serine residues were recently linked to non-canonical Wnt/JNK signalling (Oishi et al., 2006) . A full biochemical analysis of the interaction between Rcsd1 and CapZ, however, is still missing and it is not yet clear whether the phosphorylation of both serine residues is required to prevent this interaction or whether some of the other potential phosphorylations might even enhance the interaction. Sophisticated biochemical work will be required to fully understand the mode of Rcsd1 action during cardiogenesis. Finally, it remains unclear so far what the role of Rcsd1 in the nucleus might be. The presence of a highly conserved NLS implicates that the nuclear localization of Rcsd1 might be of functional relevance. Screening for interaction partners of Rcsd1 may be a starting point to further decipher the mode of Rcsd1 action in the nucleus.
Conclusion
We here place for the first time Rcsd1 downstream of Wnt11 during cardiac development thereby providing a novel mechanism for how non-canonical Wnt signalling regulates vertebrate cardiogenesis.
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